Tofacitinib Impurity 36
- CAS No.
- 2250241-69-9
- Chemical Name:
- Tofacitinib Impurity 36
- Synonyms
- Tofacitinib Impurity 36;Tofacitinib Impurity 219;7-Tosyl-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one;7-Tosyl-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one (Tofacitinib Impurity);4H-Pyrrolo[2,3-d]pyrimidin-4-one, 3,7-dihydro-7-[(4-methylphenyl)sulfonyl]-
- CBNumber:
- CB53166559
- Molecular Formula:
- C13H11N3O3S
- Molecular Weight:
- 289.31
- MDL Number:
- MFCD34603180
- MOL File:
- 2250241-69-9.mol
Tofacitinib Impurity 36 Preparation Products And Raw materials
Raw materials
Preparation Products
Tofacitinib Impurity 36 Suppliers
Global( 22)Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
ANHUI WITOP BIOTECH CO., LTD | +8615255079626 | eric@witopchemical.com | China | 23556 | 58 |
China National Standard Pharmaceutical Corporation Limited | +8615391658522 | overseasales@yongstandards.com | China | 11927 | 58 |
Wuxi Zhongkun Biochemical Technology Co., Ltd. | 0510-85629785 18013409632 | sales@reading-chemicals.com | China | 15185 | 58 |
Jinan SanZhi Pharmaceutical Technology Co., Ltd. | 15053191807 | sales_sanzhi@163.com | China | 286 | 55 |
Shenzhen SUNGENING Bio-Medical Co., Ltd. | 0755-28967200 13631290199 | wxf@sungening.com | China | 9592 | 60 |
Jinan blalong chemical co. LTD | 2710913286@.com | 1513643261@qq.com | China | 14253 | 58 |
Accela ChemBio Co.,Ltd. | 021-50795510 4000665055 | sales@accelachem.com | China | 11728 | 58 |
Shenzhen ruikai de biotechnology co., ltd. | 0755-61348847 17820674378 | 2682116078@qq.com | China | 7844 | 58 |
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd | 15850510341 | shiqingran@wzxchem.com | China | 3620 | 58 |
Cato Research Chemicals Inc. | 020-81215950 4000-868-328 | customer@uwalab.com | United States | 10413 | 58 |
2250241-69-9(Tofacitinib Impurity 36)Related Search:
Tofacitinib Impurity 2
Tofacitinib Impurity 45
Tofacitinib Related Compound
1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine
N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide
3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
Tofacitinib Impurity
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)-
7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]-
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
1of4
Tofacitinib Impurity 36
Tofacitinib Impurity 219
7-Tosyl-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one
4H-Pyrrolo[2,3-d]pyrimidin-4-one, 3,7-dihydro-7-[(4-methylphenyl)sulfonyl]-
7-Tosyl-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one (Tofacitinib Impurity)
2250241-69-9